H H Fiebig, D Schmähl. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » 9,10-Dimethyl-1,2-benzanthraceneAnimalsAntineoplastic Agents/administration & dosageAntineoplastic Agents/toxicityCarmustine/administration & dosageCarmustine/toxicityCastrationCyclophosphamide/administration & dosageCyclophosphamide/toxicityDoxorubicin/administration & dosageDoxorubicin/toxicityDrug Therapy, CombinationErgolines/administration & dosageFemaleFluorouracil/administration & dosageFluorouracil/toxicityMammary Neoplasms, Experimental/chemically inducedMammary Neoplasms, Experimental/drug therapyMammary Neoplasms, Experimental/therapyMethotrexate/administration & dosageMethotrexate/toxicityMethylnitrosoureaMiceNitrosourea Compounds/administration & dosagePrednisolone/administration & dosagePrednisolone/toxicityRatsTamoxifen/administration & dosageVincristine/administration & dosageVincristine/toxicity
Substances： See more » Antineoplastic AgentsErgolinesNitrosourea CompoundsTamoxifen9,10-Dimethyl-1,2-benzanthraceneVincristineMethylnitrosoureaergocornineDoxorubicinCyclophosphamidePrednisoloneFluorouracilCarmustineMethotrexate
Year: 1980 PMID： 6768114 DOI： 10.1007/978-3-642-81406-8_12
Source DB: PubMed Journal: Recent Results Cancer Res ISSN： 0080-0015